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This latter group is subdivided into localized and systemic histiocytic sarcomas and the splenic hemophagocytic sarcoma (HHS). Different histiocytic subtypes are thought to be the origin of these different histiocytic diseases (1) and can be identified with a panel of cluster of differentiation (CD) markers on fresh material.
However, for routine classification on formalin-fixed, paraffin-embedded (FFPE) samples, unfortunately no definitive immunohistochemical (IHC) panel is available yet.
The terminology and diagnostic criteria applied to this group of diseases has evolved over the past 20 years. Reports of canine HS in the literature use a variety of different inclusion criteria for HS, some of which are now outdated, and many did not utilize IHC to verify the histiocytic nature of the tumors or even included dogs as HS case without any pathological examination (16) . None of the reports included a large number of dogs of the same breed. In addition, in recent years, HS seems to have become a synonym for any poorly differentiated round-polygonal cell tumor.
This makes it difficult to determine specific morphological and IHC criteria to be used by pathologists for diagnosis of HS and thus the diagnosis of HS and HHS remains a matter of some debate.
Therefore the goal of this study was to establish morphological and IHC criteria, for routine use on FFPE samples and cytological smears, for the recognition and differentiation of canine HS and its subtypes within the wide spectrum of histiocytic diseases and other malignant tumors in a large number of dogs of the two breeds particularly affected by canine HS. IHC procedure. Due to a lack of specific IHC stains that accurately separate different types of sarcomas, a selection of antibodies was used to differentiate between specific diagnoses. In order to indicate a histiocytic origin, all histological samples were also stained and evaluated with the CD18 antibody (CA16.3C10, IgG1, anticanine mouse monoclonal; P.F. Moore, University of California, Davis, CA, USA), which is a leukocyte marker and is able to differentiate neoplasms of leukocyte origin from other types of sarcomas. The risk of bias was minimized by several measures: the first diagnosis was not known to the revising pathologist/cytologist; the diagnosis was only made with the help of a scoring system based on standardized morphological criteria combined with IHC; all IHC was performed in the same laboratory at the same time period with the same antibody and procedure. If any doubt existed, only a probable diagnosis was reported, decision by consensus was undertaken for agreement on difficult cases and for the determination of final morphological criteria for the diagnosis of HS. Table I and II, respectively.
Material & Methods

Selection
Of 654 dogs (365 BMD and 289 FCR) with the diagnosis of HS, it was possible to further sub-classify these into localized HS (n=318) and disseminated HS (n=336). Localized HS was significantly (p<0.001) more frequent in FCR (60.6%) than in BMD (39.2%). Of the HS cases, 45 BMD and eight FCR met the inclusion criteria and were identified as being of the HHS subtype.
Revision
.
Discussion
In the present study, a large series of histiocytic sarcomas and its differential diagnoses in BMD and FCR were selected based on their initial diagnosis during a routine examination by a clinical or anatomic pathologist. It was found that a large proportion of these initial diagnoses, 47.5% and 46.3% for histology and cytology, respectively, were changed by the revision process to different diagnoses, with the help of a scoring system on several standardized morphological criteria combined with IHC. In the group of sarcomas, it was not always possible in this study to further characterize them after being excluded as of histiocytic origin. and other biopsies with a small width (<2 mm) were only assessable for a limited number of the morphological features. This resulted in a less reliable morphological diagnosis, while the performance of IHC is often less reliable in such small samples due to false-positive edge staining. Therefore taking such small biopsies is discouraged and surgical biopsies are highly recommended, which was also already concluded in human pathology (22) .
Although the differential diagnosis of a sample suspected of being a malignant tumor, with a possibility of HS, can already be narrowed down with morphological examination with strict differentiating morphological criteria only, all histological samples were also stained and evaluated with the CD18 antibody, as an extra confirmation of the leukocyte origin of tumor cells. CD3 and CD79a should be added, as in this study morphology alone was also insufficient to differentiate HS from ML. A fair proportion of ML and HS switched from diagnosis between first and second evaluation. In order to indicate the macrophage origin of the HHS subtype, CD11d staining was helpful.
Some cases of HS in our study had weak or negative staining for CD18.
Absence, weak or variable IHC staining intensity can be caused by the formaldehyde of the FFPE procedure. Formaldehyde makes recognition of antigens difficult, and overfixation with this preserving agent can result in detection failure (or only weak reaction) (23) . Differences in the degree of differentiation of the histiocytic tumor cells can result in different intensity of staining within and between cases (17). Variability in staining intensity for lysozyme in MH is related to the degree of anaplasia of the neoplasia (7, 17) .
Considering the fact that a large proportion of diagnoses were changed during the revision process, it is important to identify the cyto-/histomorphological characteristics of histiocytic sarcomas. Therefore, in the present study these aspects of histiocytic sarcomas were studied in 654 unique cases of two different predisposed breeds, BMD (n=365) and FCR (n=289). The systematic scoring of the morphological characteristics was performed on both histology and cytology slides, when both available, or on one of them. Although the tumors in both breeds had several common characteristics, several significant differences of HS morphology were found between BMD and FCR (Table III) Phagocytosis of erythrocytes and leukocytes by the tumor cells was significantly more often seen in BMD than in FCR, but this could have been related to the more frequent presence in disseminated HS. This has been reported before in canine HS (1, 6, 7, 28, (33) (34) (35) (36) (37) (38) (39) and is also often seen in human HS, sometimes simultaneously with spindle cells (40, 41) . In addition, extramedullary hematopoiesis was seen more often in BMD than in FCR. This could well have been related to the higher amount of erythrophagocytosis seen in HS in BMD. As hematological data were missing in this study, a correlation with anemia could not be established.
Extramedullary hematopoiesis is also reported in canine HHS (8) . Invasive behavior of the tumor cells, both in blood and lymph vessels and in liver and lymph node sinusoids, was sometimes noted (up to 7.1%) in BMD, but was almost absent from FCR. This invasive behavior was exclusively found in disseminated HS. A sinusoidal pattern has been recognized before in canine HS in lymph nodes (37) and in the liver including invasion of the portal areas (28) , and has been associated with the HHS subtype (8) . It is also reported in human HS (54, 55) .
Red pulp and intravascular invasion with phagocytosis is recognized in canine HS (7) and HHS (8) , and in human HS (55) . Necrosis was more often seen in FCR than in the BMD and may indicate a higher malignancy/faster growing tumor than in the BMD.
Different morphological characteristics in different organs within one case were seen in this study and have been reported before (56) . Metastatic tumor cells seem to first disseminate from the early primary lesion and then acquire additional genetic defects and often exhibit properties different from the cells of the primary lesion (57) .
Macrophage-dendritic cell-HS-hybrids are possible in dogs, but tissue infiltration is discrete by subtype (8) . Further research is needed.
It can be concluded that canine HS, including its subtypes, can be recognized morphologically by a mostly easily harvested dense pleomorphic cell proliferation of (Table III) 
